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Background: Patients with Multiple Endocrine Neoplasia type 2 (MEN 2) are at high risk of developing aggressive
medullary thyroid carcinoma (MTC) in childhood, with the highest risk in those with MEN type 2B (of whom >95%
have an M918T RET proto-oncogene mutation). Metastatic MTC has been reported as young as 3 months of age.
Current guidelines recommend prophylactic thyroidectomy within the first year of life for MEN 2B.
Patient findings: We report a 9-week-old infant with MTC due to familial MEN 2B. A full-term male infant, born to
a mother with known MEN 2B and metastatic MTC, had an M918T RET proto-oncogene mutation confirmed at
4 weeks of age. He underwent prophylactic total thyroidectomy at 9 weeks of age. Pathology showed a focal
calcitonin-positive nodule (2.5 mm), consistent with microscopic MTC.
Summary: This case highlights the importance of early prophylactic thyroidectomy in MEN 2B. Although current
guidelines recommend surgery up to a year of life, MTC may occur in the first few weeks of life, raising the
question of how early we should intervene. In this report, we discuss the risks, benefits and barriers to performing
earlier thyroidectomy, soon after the first month of life, and make suggestions to facilitate timely intervention.
Prenatal anticipatory surgical scheduling could be considered in familial MEN 2B. Multidisciplinary collaboration
between adult and pediatric specialists is key to the optimal management of the infant at risk.
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Multiple Endocrine Neoplasia type 2 (MEN 2) is an
autosomal dominant hereditary cancer syndrome with a
prevalence of about 1 in 30,000 [1]. Germline mutations
in the RET (Rearranged during Transfection) proto-
oncogene account for the three distinct clinical pheno-
types, MEN 2A, MEN 2B and familial medullary thyroid
cancer (MTC). All the MEN 2 syndromes are associated
with MTC, which frequently metastasizes to regional
and distant sites, and is the primary MEN-related cause
of death in affected patients. Thus, prophylactic thyroi-
dectomy is recommended in asymptomatic patients with
pathogenic mutations, before the development of MTC.* Correspondence: meilan.rutter@cchmc.org
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reproduction in any medium, provided the orStrong genotype-phenotype correlations have enabled
risk stratification and form the basis of recommenda-
tions for timing of prophylactic surgery [2].
MEN 2B is the rarest and most aggressive form of
MEN 2, and is associated with early-onset MTC, as well
as pheochromocytoma, mucosal neuromas, intestinal
ganglioneuromas and a Marfanoid habitus. More than
95% of cases with MEN 2B have an M918T mutation in
exon 16 of the RET proto-oncogene; a further 2-3% have
an A883F mutation [3]. Both mutations are classified as
level 1 or ATA-D, the highest risk category for aggressive
MTC, according to the current ATA (American Thyroid
Association) guidelines [1]. These guidelines state that
"infants with ATA-D mutations (MEN 2B) should
undergo prophylactic thyroidectomy as soon as possible
and within the first year of life in an experienced ter-
tiary care setting". Former consensus guidelines hadl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Shankar et al. International Journal of Pediatric Endocrinology 2012, 2012:25 Page 2 of 4
http://www.ijpeonline.com/content/2012/1/25recommended thyroidectomy "within the first six months
and preferably within the first month of life" [2].
We describe one of the youngest patients with biopsy-
proven MTC at 9 weeks of age associated with familial
MEN 2B. The manifestation of MTC at this young age
underscores the importance of early diagnosis and thyr-
oidectomy. Although current guidelines allow for sur-
gery up to a year of age, MTC may occur much earlier
in infancy, raising the question of how soon intervention
should optimally occur. We make simple and practical
suggestions to achieve an earlier thyroidectomy, after
the first month of life, in these high-risk individuals.
Case presentation
A male infant was born to a mother with known MEN
2B due to an M918T RET proto-oncogene mutation.
His mother presented at 13 years of age with mucosal
neuromas, a typical Marfanoid habitus and MTC. She
underwent total thyroidectomy and lymph node dissec-
tion. Histopathology confirmed multifocal MTC with
multiple lymph node metastases. She later developed
hepatic and pulmonary metastases, and underwent re-
section of a pheochromocytoma at age 25 years. She is
currently alive and well at 27 years of age, but with per-
sistent MTC and a serum calcitonin concentration over
2000 pg/mL.
The infant was delivered at term with a birth weight of
3.26 kg, and had no symptoms or signs of MEN 2B. He
underwent genetic testing at 4 weeks of age, which con-
firmed the same mutation. He was then referred to
Pediatric Otolaryngology and Endocrinology. His circu-
lating calcitonin concentration at 4 weeks was 81 pg/mL
(41 pg/mL is the 95th percentile for age less than
6 months). He underwent prophylactic thyroidectomy at
9 weeks of age. Parathyroid glands were visualized and
left in situ. There were no visible or palpable lymphFigure 1 A thyroidectomy specimen of the patient reveals a 2.5 mm,
The tumor cells are relatively uniform with moderately eosinophilic cytopla
(1A and inset). The tumor cells show strong reactivity to calcitonin immunonodes at the time of surgery. His perioperative course
was unremarkable, and he recovered without complica-
tion. Histopathology of the thyroid showed a 2.5 mm
nodular lesion with infiltrative borders (Figure 1A) and
cells which were reactive for calcitonin on immunohisto-
chemical staining (Figure 1B), consistent with micro-
scopic MTC. There was no vascular invasion.
Post-operatively, his serum calcitonin concentration
declined to 8 pg/mL, and has remained in this range
since. At 2 years of age, his carcinoembryonic antigen
concentration is 2.1 ng/mL (normal <5 ng/mL) and
thyroglobulin is undetectable (consistent with no re-
sidual thyroid tissue). He has no residual thyroid tissue
or lymph node enlargement by ultrasound examination.
He has normal growth and development, but has
chronic constipation due to biopsy-proven intestinal
ganglioneuromatosis. He has absent tearing. He has
developed a tongue nodule, likely a mucosal neuroma.
Discussion
We report one of the youngest patients in the literature
with MTC due to familial MEN 2B at 9 weeks of age.
Histologically, the tumor was 2.5 mm in size and had in-
filtrating borders in focal areas, confirming the diagnosis
of microscopic MTC and distinguishing it from C-cell
hyperplasia [4]. Other reports of early MTC in MEN 2B
include a microscopic MTC in a 9-week-old infant, but
with a de novo mutation [5], and metastatic MTC in a
3-month-old infant with familial MEN 2B [6].
Although extensive long term follow-up data is lacking
in MEN 2B [7], the benefit of prophylactic thyroidect-
omy before the onset of metastatic MTC is well accepted
[1]. The current guidelines state that prophylactic thyroi-
dectomy for ATA-D (highest risk) mutations must be
undertaken "as soon as possible and within the first year
of life" [1]. Our case, together with these other reports,poorly defined tumor nodule with focal infiltrative borders.
sm, and round to slightly irregular nuclei with open chromatin
histochemical staining (1B).
Index case MEN 2B
Prenatal genetic counseling
Prenatal surgical consult, scheduling of 
anticipated surgery 1 month after due date
Birth of baby
RET mutation testing soon after birth
NegativePositive
Proceed with 
surgery soon after 
the first 30 days
Cancel surgery
Figure 2 Suggested algorithm to facilitate early thyroidectomy
during infancy.
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during infancy. However, while the guidelines allow for
surgery up to a year of age, our case raises the question
as to whether intervention should occur “as soon as pos-
sible” in earlier infancy. In familial cases, when the diag-
nosis is anticipated, thyroidectomy soon after the first
month of life could be considered.
Current hurdles to performing prophylactic total thyr-
oidectomy in the first few months of life include: 1) time
delays in arriving at a diagnosis and scheduling surgery,
2) concern that surgical and anesthetic risks outweigh
the benefits of surgery at that age, and 3) concern for
iatrogenic hypothyroidism.
Any impediment to the multiple steps associated with
the treatment of these patients, including genetic testing,
referral to a pediatric thyroid surgeon, pre-surgical evalu-
ation and procedure scheduling, could result in signifi-
cant surgical delay. An early diagnosis should be made by
genetic testing of at risk infants soon after birth, or even
prenatally. The ATA guidelines recommend that all
patients with MEN 2B of child-bearing age should be
offered prenatal genetic counseling [1]. This includes dis-
cussion of the options of pre-implantation genetic testing
(enabling implantation of unaffected embryos using
assisted reproductive techniques), chorionic villus sam-
pling, and amniocentesis. Prenatal genetic counseling
helps parents understand the risk of having an affected
infant (50%) and the importance of prophylactic thyroi-
dectomy in an asymptomatic baby, and facilitates RET
testing early in the newborn period. In addition, if surgi-
cal referral and scheduling of anticipated thyroidectomy
(contingent upon subsequent confirmation of the diagno-
sis) occur prenatally in familial cases, postnatal genetic
confirmation may become the sole rate-limiting step. Of
note, while pre-operative calcitonin measurement is
recommended, calcitonin concentrations should be inter-
preted with caution in infants below 6 months of age and
should not be used to dictate surgical decisions [1].
There are potential surgical and anesthetic risks asso-
ciated with performing thyroidectomy during early in-
fancy. Children younger than six years of age have the
highest rate of complications following thyroidectomy as
compared with adults, although outcomes may be
improved by referral to high-volume surgeons [8]. Sig-
nificantly delaying prophylactic thyroidectomy may im-
prove patient safety, but is not an option in MEN 2B
when surgery has to be undertaken by a year of age, and
possibly sooner. There are no formal studies of thyroi-
dectomy outcomes in infants below a year of age. How-
ever, it is our opinion that there is little additional
surgical risk for an infant one month of age compared
with six months of age when performed by an experi-
enced pediatric thyroid surgeon working in an environ-
ment with appropriate pediatric resources. Surgicalcomplications include hypoparathyroidism and recurrent
laryngeal nerve injury. Post-operative hypoparathyroid-
ism does not appear to be related to the age of surgery in
children with MEN [9], while the risk of both complica-
tions is increased by lymph node dissection [10]. An
added benefit of early surgery soon after a month of age
in familial MEN 2B is that central neck dissection may
be avoided. According to the ATA guidelines, “thyroi-
dectomy prior to lymph node metastases obviates the
need for central compartment lymph node dissection
which is associated with a higher rate of hypoparathyr-
oidism and vocal cord paralysis” [1].
There is evidence that the risk of general anesthesia is
greater in a child under one year of age [11]. However,
anesthetic risk can be attenuated by carefully screening
for children with a history of prematurity, congenital
heart disease, or other congenital abnormalities [12]. We
typically wait until a full-term infant is one month of age
before administering anesthesia for an elective procedure
in order to minimize the risk of post-operative apnea.
We therefore suggest that thyroid surgery be undertaken
after 30 days of age in a child with MEN 2B.
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hypothyroidism are a potential problem. This concern
should not warrant delaying thyroidectomy; instead, in-
tensive monitoring and careful replacement of levothyr-
oxine is essential [13].
Conclusions
Our case highlights the importance of early prophylactic
thyroidectomy, and raises consideration of performing
surgery “as soon as possible” after the first month of life
in familial MEN 2B, without waiting up to a year of age.
After considering risks and benefits, we propose a sim-
ple and practical algorithm to facilitate timely prophylac-
tic thyroidectomy in early infancy in familial MEN 2B
(Figure 2). Families should receive prenatal genetic
counseling according to ATA guidelines [1]. In addition,
we suggest prenatal referral to a surgeon with expertise
in pediatric thyroid surgery, with scheduling of antici-
pated surgery. After birth, if RET testing is positive, sur-
gery may be performed soon after a month of age. This
approach would eliminate time lost in surgical evalu-
ation and scheduling after genetic results are known.
Ideally, surgery should be undertaken at a tertiary care
center by an experienced pediatric thyroid surgeon. In
addition, the participation of a pediatric anesthesiologist
and access to skilled post-operative pediatric nursing
would minimize the risk of peri-operative complications.
While prophylactic thyroidectomy in inherited MEN
2B is a unique pediatric problem, the gatekeepers to ap-
propriate referral and timely intervention are frequently
adult endocrinologists and obstetricians. Early collabor-
ation between adult and pediatric specialists is key to
optimizing the management of the infant with familial
MEN 2B.
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